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Xenopus oocyteerization of T-type Ca2+ channel isoforms (Cav3.1, Cav3.2, and Cav3.3) has shown
that all of the isoforms are low voltage-activated around resting membrane potential, but their current
kinetics are distinctly different, with the activation and inactivation kinetics of the Cav3.1 and Cav3.2 channels
being much faster than those of the Cav3.3 channel. We previously reported that multiple structural regions
of the Cav3.3 T-type channel participate in determining its current kinetics. Here we have evaluated the
relative contributions of individual cytoplasmic and trans-membrane regions to the current kinetics of the
channel, by systematically replacing individual regions of Cav3.3 with the corresponding regions of Cav3.1.
Introduction of the Cav3.1 III–IV loop into the Cav3.3 backbone accelerated both the activation and
inactivation kinetics more prominently than any other intracellular loop or tail. Among the trans-membrane
domains, introduction of the domain I of Cav3.1 into Cav3.3 accelerated both the activation and inactivation
kinetics most effectively. These ﬁndings suggest that the current kinetics of the Cav3.3 channel are
differentially controlled by several structural regions, among which the III–IV loop and domain I are the most
prominent in governing both activation and inactivation kinetics.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionCa2+ entry through T-type Ca2+ channels (T-channels) mediates a
variety of physiological functions such as muscle contraction,
pacemaker activity, hormone secretion, acrosome reactions, rebound
bursting, and thalamic oscillations [1,2]. The molecular cloning of
three isoforms of T-type Ca2+ channel α1 subunits (Cav3.1 (α1G),
Cav3.2 (α1H), and Cav3.3 (α1I)) conﬁrmed the existence of multiple
T-channels. Expression studies of the cloned T-channel isoforms
have shown that the Cav3.1 and Cav3.2 channels are activated and
inactivated much faster than the Cav3.3 channel [3–8]. Characteriza-
tion of the biophysical properties of T-channels has suggested the
differential roles of each isoform [9]. Functional characterization of
mouse knockouts of Cav3.1 or Cav3.2 provided further evidence for
the distinctive roles of each T-channel isoform [10–13].
Unlike high voltage-activated (HVA) Ca2+ channels, T-channel
currents have the following unique biophysical properties: activation
at low voltage, rapid activation and inactivation of current kinetics,
and small single-channel conductance. Li et al. [14] found that
replacement of domains I, III, or IV of the low voltage-activated Cav3.1ogang University, Shinsu-dong
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ll rights reserved.with their counterpart(s) of high voltage-activated Cav1.2 resulted in
the chimeric channels being activated at high voltage. They found that
for domain I, the pore regions (S5 to S6), but not the voltage sensor
regions (S1 to S4), were critical in determining the voltage
dependence of activation [15]. Using a similar chimeric channel
approach, Staes et al. [16] examined loop chimeric channels in which
the cytoplasmic loop connecting domains III and IV, or the C-terminal
tail of Cav3.1 was substituted for the corresponding loop of the Cav1.2
(L-type) Ca2+ channel. They found that substitution of the L-type
channel C-terminus, but not the III–IV loop, signiﬁcantly slowed the
inactivation kinetics of the C-terminal chimeric channel. Recently, we
tested which structural portion(s) contribute to the current kinetics of
T-channels using a series of chimeras between Cav3.1 and Cav3.3 [17].
When expressed in Xenopus oocytes, the Cav3.3 channel did not
acquire the fast kinetics when just one portion of the Cav3.1 channel
was substituted, and vise versa. The tendency for the channel currents
to become more Cav3.1-like the greater the extent of Cav3.1 structure
added suggested that multiple structural elements contributed to the
current kinetics of Cav3.1 and Cav3.3 channels. More recently, Hamid
et al. [18] further dissected the structural determinant(s) contributing
to the current kinetics of T-channels using additional chimeras
between the Cav3.1 and Cav3.3 channels. Their main observations
were similar to our previous ﬁndings that multiple regions contribute
to determining the current kinetics of T-channels, except that they
claimed the domain IV region has a dominant role in determining the
current kinetics.
2741H.-W. Kang et al. / Biochimica et Biophysica Acta 1778 (2008) 2740–2748In the present study, we assessed the relative contributions of
cytoplasmic loops and trans-membrane regions to the current kinetics
of Cav3.3 T-channels using systematic chimeric channels created by
substituting cytoplasmic loop(s) or trans-membrane domain(s) of
Cav3.1 in Cav3.3. Our results suggest that the current kinetics of the
Cav3.3 channel are controlled in distinct ways by multiple structural
regions, among which the III–IV loop and domain I are the most
crucial determinants among the intracellular loops and trans-
membrane domains, respectively.
2. Materials and methods
2.1. Construction of chimeras between Cav3.1 and Cav3.3 T-channels
Cloning of the rat Cav3.1 (α1G) and Cav3.3 (α1I) cDNAs was
previously reported [3,5] and their GenBank accession numbers are
AF027984 and AF086827, respectively. To facilitate generation of
chimeric constructs between the rat Cav3.1 and Cav3.3 channels, we
introduced restriction enzyme sites at borders between intracellular
and trans-membrane regions by site-directed mutagenesis using
polymerase chain reaction (PCR) methods. All PCRs were performed
using pfu DNA polymerase (Vivagen, Seoul, Korea) and ampliﬁed
fragments were veriﬁed by sequencing analysis. The restriction
enzyme sites are marked by numbers in parentheses by indicating
5′-terminal nucleotide generated by cleavage. Silent and non-silentFig. 1. Schematic diagrams of Cav3.1, Cav3.3, and their chimeras. (A) Locations of the restricti
wild-type Cav3.3. (B) T-type channel α1 subunits consist of four domains shown by the line
cylinders and thicker lines represent the regions of Cav3.1 (α1G), while white cylinders andrestriction sites used for construction of chimeric channels are
indicated by asterisks and crosses, respectively. The locations of the
restriction enzyme sites used to create chimeric Cav3.1/Cav3.3
channels are marked in Fig. 1A and schematic diagrams of individual
chimeric channels were illustrated in Fig. 1B.
pIG12L, pIG23L, and pIGcL: Constructions of plasmids, pIG12L, pIG23L,
and pIGcL were previously reported [17].
pIGNL: The fragments used are KpnI (5′-polylinker)-SphI⁎ (742,
α1G), SphI (517, α1I)-AﬂII (657,α1I), AﬂII (654, α1I)-ClaI (3902, α1I),
and ClaI (3901, α1I)-NotI (3′-polylinker). The pIGNL plasmid was
constructed by ligating the above fragments into the KpnI-
digested (5′-polylinker) and NotI-digested (3′-polylinker) plasmid
pcDNA3-α1I.
pIG34L: The fragments used are KpnI (5′-polylinker)-ClaI (3902,
α1I), ClaI (3901, α1I)-AﬂIII (4417, α1I), AﬂIII (5009, α1G)-ApaLI⁎
(5211,α1G), and ApaLI (4592,α1I)-NotI (3′-polylinker). The plasmid
pIG34L was generated by ligating the above fragments into the
KpnI-digested (5′-polylinker) and NotI-digested (3′-polylinker)
plasmid pcDNA3-α1I.
pGI34L: The fragments used are EagI (3987, α1G)-AﬂIII (5009, α1G),
AﬂIII (4413, α1I)-ApaLI (4591, α1I), and ApaLI⁎ (5208, α1G)-BglII
(5318, α1G). The plasmid pGI34L was generated by ligating theon enzyme sites used to construct the chimeric channels between wild-type Cav3.1 and
s, and six putative trans-membrane segments (S1 to S6) shown by the cylinders. Gray
thinner lines represent regions of Cav3.3 (α1I).
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(5318) plasmid pGEMHEA-α1G.
pIGN+34L, pIG12+34L, pIG23+34L, pIG34+CL, and pIGAL: These chimeric
channels were constructed by adopting additional loop (s) into
pIG34L and/or combining the single-loop chimeric constructs
explained above with pIG34L using proper restriction enzyme
sites. For example, pIGN+ 34L was generated by ligating the
fragments (KpnI (5′-polylinker)-ClaI (3902, pIGNL) and ClaI (3901,
pIG34L)-NotI (3′-polylinker, pIG34L)) into the KpnI-digested (5′-
polylinker) and NotI-digested (3′-polylinker) plasmid pcDNA3-α1I.
pIGAL was constructed by ligating the fragments KpnI (5′-
polylinker)-AﬂII (657, pIGNL), AﬂII (657, pIG12L)-NsiI (2485, pIG12L),
and Nsi (2485, pIG23L)-HindIII+ (4249, pIG23L) into the KpnI-
digested (5′-polylinker) and HindIII-digested (3651) plasmid
pIG34+CL.
IGAL+DomI, IGAL+DomII, IGAL+DomIII, and IGAL+DomIV: IGAL+DomI was
constructed by ligating the fragment KpnI (5′-polylinker)-BspEI
(2696, α1G) and BspEI+ (2038, pIG12L)-ClaI (3902, pIG23L) into the2. Current kinetics of Cav3.1, Cav3.3, and their loop chimeric channels. Currents were
resentative currents of the Cav3.1, Cav3.3, IGNL, IG12L, IG23L, IG34L, and IGCL channels evo
300 nA, respectively. (B) Average activation (left panel) and inactivation (right panel) ti
ivation and inactivation constants were derived by ﬁtting each current trace to two expo
bined with a Student–Newman–Keuls post-test: ⁎⁎, P<0.01; ⁎⁎⁎, P<0.001. (C) Averag
3.3 (×), IGNL (▪), IG12L (▴), IG23L (▾), IG34L (◆), and IGCL (•) at various potentials. DatKpnI-digested (5′-polylinker) and ClaI-digested (3901) plasmid
pIGAL. The other chimeric channels were similarly constructed by
adopting a trans-membrane domain into pIGAL and/or combining
the chimeric constructs constructed with pIGAL using proper
restriction enzyme sites.
2.2. Functional expression of the Cav3.1, Cav3.3, and chimeras in
Xenopus oocytes
The cDNA constructs were linearized at their 3′ ends by AﬂII or
NotI. Complementary RNA (cRNA) transcripts were synthesized from
the linearized cDNAs using T7 RNA polymerase (Ambion, Austin, TX).
The cRNAs were injected into oocytes at concentrations of 10–50 ng/
50 nl using a Drummond Nanoject pipette injector (Parkway, PA)
attached to a Narishige micromanipulator.
Preparation of Xenopus oocytes was previously described [17].
Brieﬂy, ovary lobes were surgically separated from female Xenopus
laevis (Xenopus Express, Le Bourg, France). Oocytes were treated with
collagenase (lyophilized, 10 mg/ml, Gibco-BRL, Gaithersburg, MD,elicited by test pulses to varying voltages from a holding potential of −90 mV. (A)
ked by test pulses to −40 and 0 mV. Scale bars on the X and Y axes represent 100 ms
me constants of currents evoked by test pulse to −40 (white bar) and 0 (black bar) mV.
nentials (see Materials and methods). Differences were evaluated by one-way ANOVA
e activation (left panel) and inactivation (right panel) time constants for Cav3.1 (⁎),
a represent mean±S.E.M. (n=13–23).
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Louis, MO, USA) about 50 min in Ca2+-free OR2 solution (82.5 mM
NaCl, 2.5 mM KCl, 1 mM MgCl2, 5 mM HEPES, pH 7.6) to remove their
follicle membranes. Defolliculated oocytes were chosen under a
microscope and then recovered overnight in SOS solution (100 mM
NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES, 2.5 mM
pyruvic acid and 50 μg/ml gentamicin, pH 7.6).
2.3. Electrophysiological recordings in oocytes and data analysis
Currents from oocytes weremeasured at room temperature between
3 and 6 days after cRNA injection using a two-electrode voltage-clamp
ampliﬁer (OC-725C, Warner Instruments, Hamden, CT). Microelectrodes
were pulled from capillaries (Warner Instruments, Hamden, CT) using a
pipette puller, and ﬁlled with 3 M KCl, and the electrode resistance was
0.6–1.0 MΩ. The Ba2+ recording solution contained (in mM): 10 Ba(OH)2,
90 NaOH, 1 KOH, 5 HEPES (pH 7.4 with methanesulfonic acid). The
currents were usually sampled at 5 kHz, and low pass ﬁltered at 1 kHz
using the pClamp system (Digidata 1320A and pClamp 8; Axon
instruments, Foster City, CA). Peak currents and exponential ﬁts to
currents were analyzed using Clampﬁt software (Axon instruments).
Graphical representation of the data was obtained with Prism software
(GraphPad, San Diego, CA). Data are given as mean±S.E.M. Differences
were tested for signiﬁcance using one-way AVOVA combined with a
Student–Newman–Keuls post-test and Student's unpaired t test.
3. Results
This study was initiated to assess the relative contributions of the
main cytoplasmic regions to the current kinetics of the Cav3.3 channel.
We constructed ﬁve single-loop chimeric channels (IGNL, IG12L, IG23L,
IG34L, and IGCL; Fig. 1) by replacing individual cytoplasmic regions of
the slow Cav3.3 with their counterpart regions in the fast Cav3.1. When
cRNA of wild Cav3.1, Cav3.3 or each single-loop chimeric channel was
injected into Xenopus oocytes, expression of the channels was
detected as a strong inward current in 10 mM Ba2+ solution. Fig. 2A
displays representative traces of the wild type Cav3.1 and Cav3.3
channels and the chimeric channels evoked by test potentials of −40
and 0 mV from a holding potential of −90 mV. Analysis of the current
kinetics showed that the activation time constants (ms) of the Cav3.1
current were 4.4±0.5 at −40 mV and 0.9±0.1 at 0 mV, while the
inactivation time constants (ms)were 16.7±1.5 at −40mV and 7.9±0.6
at 0 mV. In comparison, the activation time constants of Cav3.3 were
55.9±7.8 at −40 mV and 11.7±1.0 at 0 mV, while the inactivation time
constants were 235.8±7.7 at −40 mV and 91.4±5.2 at 0 mV (n=15–21;Table 1
Biophysical properties of Cav3.1, Cav3.3, and their chimeric channels
V50 for ACT Slope(k) V50 for INACT Slope
Cav3.1 −38.2±0.6 6.2±0.1 −63.7±0.6 3.8±
Cav3.3 −34.9±0.7 5.8±0.1 −55.9±0.5 5.4±
IGNL −38.4±1.2 5.6±0.1 −57.7±1.2 6.3±
IG12L −41.8±0.6 4.8±0.1 −61.3±0.6 5.0±
IG23L −38.8±0.9 5.9±0.1 −58.3±0.6 6.0±
IG34L −44.4±1.2 5.5±0.3 −64.5±0.7 4.7±
IGCL −32.3±1.2 6.3±0.2 −52.7±0.6 4.5±
IGN+34L −45.3±1.5 5.5±0.1 −64.7±0.9 5.0±
IG12+34L −48.9±0.7 5.2±0.1 −69.9±0.6 4.3±
IG23+34L −45.7±1.5 6.0±0.1 −66.5±0.9 5.0±
IG34+CL −42.2±0.9 6.6±0.3 −61.0±0.7 3.9±
IGAL −53.9±0.7 5.1±0.2 −70.8±0.7 3.4±
IGAL+DomI −40.4±0.8 6.5±0.1 −64.9±0.9 3.4±
IGAL+DomII −45.4±1.4 6.2±0.1 −66.7±1.2 3.8±
IGAL+DomIII −49.0±3.0 5.7±0.2 −66.4±2.2 3.5±
IGAL+DomIV −47.7±0.7 5.0±0.1 −68.3±0.5 4.1±
Data represent mean±S.E.M. (n=6–23).Fig. 2B). These data indicate that the Cav3.1 current was activated and
inactivated roughly 10 fold more rapidly than the Cav3.3 current,
consistent with previous reports [5,17,18].
The activation and inactivation time constants of the ﬁve loop
chimeric channels (IGNL, IG12L, IG23L, IG34L, and IGCL) are plotted against
test potentials in Fig. 2C. Of the ﬁve single-loop chimeric channels, the
IG34L chimera (Cav3.3 backbone substitutedwith the Cav3.1 III–IV loop)
displayed signiﬁcantly faster activation and inactivation kinetics
(τact=23.0±2.5 at −40 mV and 5.7±0.4 at 0 mV; τinact=123.0±8.9 at
−40 mV and 56.8±3.4 at 0 mV, n=23) than the other four chimeras
channels aswell aswild type Cav3.3. This suggests that the Cav3.1 III–IV
loop plays the most prominent role in accelerating both activation and
inactivation of Cav3.3. It is of interest that substitution of Cav3.1 I–II
altered the activation and inactivation kinetics of Cav3.3 differently: the
activation kinetics of the IG12L chimera at test potentials higher than
−30 mV were signiﬁcantly faster than those of wild type Cav3.3
(P<0.001, n=13), whereas the inactivation kinetics were signiﬁcantly
slower (P<0.01, n=13; Fig 2B and C; Table 1). The inactivation kinetics
of the IGCL chimera (Cav3.3 backbone substituted with the Cav3.1
carboxyl terminus) were signiﬁcantly faster than those of Cav3.3
(P<0.01, one-way ANOVA, n=21), but the activation kinetics were no
different from those of Cav3.3. The chimeric channels substituted with
the amino terminus or II–III loop had activation and inactivation rates
similar to those of Cav3.3.
The ﬁnding that the III–IV loop plays the most prominent role in
accelerating current kinetics raised the question of whether transfer of
another Cav3.1 intracellular region to IG34L could further modulate the
current kinetics of IG34L. To test this, we constructed the four double-
loop chimeric channels (IGN+34L, IG12+34L, IG23+34L, and IG34L+CL; Fig.
1) by replacing the individual cytoplasmic loops of the IG34L chimera
with the N-terminus, I–II loop, II–III loop, or C-terminus of Cav3.1.
Functional expression of all these double-loop chimeric channels in
Xenopus oocytes was detected as large inward currents in response
to serial step pulses from a holding potential of −90 mV (Fig. 3A).
Analysis of the current kinetics of the double-loop chimeric channels
showed that, at test potentials higher than −30 mV, the IG12+34L
chimeric channel exhibited faster activation kinetics than IG34L
(τact =3.4±0.3 vs 5.7±0.4 at 0 mV; P<0.05, n=13), but slower
inactivation kinetics (τinact values=76.9±4.7 vs 56.8±3.4 at 0 mV;
P<0.05, n=13; Fig. 3B). By comparison, substitution of the Cav3.1 C-
terminus into IG34L signiﬁcantly slowed its activation kinetics at most
test potentials (P<0.01, n=13; Fig. 3B and C), but did not signiﬁcantly
alter its inactivation kinetics. In contrast to the role of the C-terminus,
substitution of the Cav3.1 N-terminus into IG34L did not affect its
activation kinetics, but signiﬁcantly slowed its inactivation kinetics at(k) τact τinact
−40 mV 0 mV −40 mV 0 mV
0.2 4.4±0.5 0.9±0.1 16.7±1.5 7.9±0.6
0.2 55.9±7.8 11.7±1.0 235.8±7.7 91.4±5.2
0.3 59.0±9.1 12.4±1.3 257.5±11.3 99.7±7.6
0.1 47.5±3.7 6.4±0.6 250.6±19.3 127.0±11.6
0.1 50.2±5.8 11.0±1.0 249.5±21.8 101.9±9.7
0.1 23.0±2.5 5.7±0.4 123.0±8.9 56.8±3.4
0.1 49.0±4.6 11.3±0.9 224.3±10.7 66.8±3.3
0.1 31.6±3.4 7.2±0.6 164.8±16.1 81.4±8.1
0.1 16.1±1.6 3.4±0.3 110.1±6.4 76.9±4.7
0.1 22.8±2.2 5.8±0.6 126.0±10.5 67.4±5.6
0.1 44.7±5.5 8.6±1.0 142.0±8.3 64.4±4.3
0.1 18.7±2.1 4.6±0.5 111.2±5.8 83.7±5.6
0.1 13.8±0.9 2.5±0.2 50.7±5.7 22.0±1.2
0.1 19.3±2.3 3.7±0.5 63.7±8.8 37.6±3.8
0.1 21.3±2.8 3.7±0.4 96.5±6.7 61.0±6.1
0.1 8.9±1.1 2.2+0.3 88.7±15.6 48.2±8.9
Fig. 3. Effects of substituting intracellular loop(s) or tails on the current kinetics of IG34. (A) Representative currents of the IG34, IGN+34L, IG12+34L, IG23+34L, IG34L+CL, and IGAL chimeric
channels evoked by test pulses to −40 and 0mV. Scale bars on the X and Yaxes indicate 100ms and 500 nA, respectively. (B) Mean activation (left panel) and inactivation (right panel)
time constants measured from current traces evoked at −40 and 0 mV are shown as bar graphs. Differences were evaluated by one-way ANOVA: ⁎, P<0.05; ⁎⁎, P<0.01. (C) Mean
activation (left panel) and inactivation (right panel) time constants for Cav3.1 (⁎), Cav3.3 (×), IG34L (◆), IGN+34L (□), IG12+34L (▵), IG23+34L (▿), IG34+CL (◊), and IGAL (○) as a function of
test potentials. Data represent mean±S.E.M. (n=8–23).
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other hand, IG23+34L did not showany signiﬁcant difference from IG34L
in its activation or inactivation kinetics (Fig. 3B and C). With regard to
inactivation rates, none of the double-loop chimeras had faster
kinetics than IG34L, supporting the view that it is prominently that
the III–IV loop controls the inactivation kinetics of T-channels.
Next we constructed IGAL (Fig. 1) to see how replacement of all
the main intracellular regions of Cav3.3 with their counterparts in
Cav3.1 affected the current kinetics of the Cav3.3 backbone. Analysis
of IGAL currents showed that their activation kinetics were similar to
those of IG12+34L, but still signiﬁcantly slower than those of Cav3.1.
The inactivation kinetics of IGAL were similar to those of IG12+34L and
IGN+34L, but signiﬁcantly slower than those of IG34L at test potentials
higher than −30 mV (τinact of IGAL and IG34L=83.7±5.6 vs 56.8±3.4 at
0 mV; P<0.01, n=8; Fig. 3B and C). As shown by IG12L and IG12+34L, the
substituted I–II loops tend to accelerate the activation kinetics of the
chimeras but to interfere somewhat with the inactivation kinetics.
The fact that substitution of any one cytoplasmic region or even of all
the main cytoplasmic structures was not sufﬁcient to convert the
slow Cav3.3 channel to a fast channel like Cav3.1 suggests that the current
kinetics of a Cav3.3 T-type channel are controlled not only by its
cytoplasmic loops and/or tails, but also by its trans-membrane domain(s).To assess the relative contributions of domains I, II, III, and IV
together with the cytoplasmic regions to current kinetics, we
constructed four trans-membrane chimeric channels (IGAL +Dom I,
IGAL +Dom II, IGAL +Dom III, or IGAL +Dom IV) by substituting the individual
domains of Cav3.1 for the corresponding domains of IGAL. Represen-
tative traces of IGAL +Dom I, IGAL +Dom II, IGAL +Dom III, or IGAL +Dom IV
activated at test potentials of −40 and 0 mV from a holding potential of
−90 mV are shown in Fig. 4A. Substitution of Cav3.1 domains I or IV into
IGAL signiﬁcantly accelerated the activation kinetics of the chimeras
(P<0.01 at 0mV,n=6–9; Fig. 4B andC; Table 1),whereas Cav3.1 domains II
or III didnot signiﬁcantlyaffect their activationkinetics.With regard to the
inactivation kinetics, transfer of each of the Cav3.1 domains to IGAL
accelerated the inactivation kinetics, with domain I being the most
effective (P<0.001,n=6–9; Fig. 4B and C). The relative contributions of the
four domains to the inactivation kinetics were in the following order:
domain INdomain II≥domain IV≥domain III. These ﬁndings suggest that
the individual domainsmakedistinct contributions to the current kinetics.
The normalized current–voltage relationships of all the chimeric
channels are compared with those of Cav3.1 and Cav3.3 in Fig. 5A. The
thresholds and peak currents of most of the chimeras tended to be
negatively shifted when compared with their parent channels (Cav3.1
and Cav3.3), whereas those of IGCL tended to be positively shifted. Peak
Fig. 4. Effects of substituting individual trans-membrane domains on the current kinetics of IGAL. (A) Representative current traces of IGAL, IGAL+Dom I, IGAL+Dom II, IGAL+Dom III, and IGAL+
Dom IV evoked by test pulses to −40 and 0 mV. Scale bars on the X and Y axes indicate 100 ms and 300 nA, respectively. (B) Mean average activation (left panel) and inactivation (right
panel) time constants of currents evoked by test pulses to −40 and 0mVare shown as bar graphs. Differenceswere evaluated by one-wayANOVA: ⁎⁎, P<0.01; ⁎⁎⁎, P<0.001. (C) Average
activation (left panel) and inactivation (right panel) time constants for Cav3.1 (⁎), Cav3.3 (×), IGAL (○), IGAL/DomI ( ), IGAL/DomII ( ), IGAL/DomIII ( ), and IGAL/DomIV ( ) at different test
potentials. Data represent mean±S.E.M. (n=6–21).
2745H.-W. Kang et al. / Biochimica et Biophysica Acta 1778 (2008) 2740–2748current amplitudes detected at potentials between −39 and −18 mV
were in the following order: IGAL<IG12+34L≤ IGAL+DomIII≤ IGAL+DomIV≤
IGN+34L≤ IG23+34L≤ IG34L≤ IG23+34L≤ IG 34+CL≤ IG12L≤ IGALL+Dom I≤ IGNL≤
Cav3.1≤Cav3.3<IGCL. The activation curves and steady-state inactivation
curves were obtained by ﬁtting the data to the Boltzmann equation
(Fig. 5B and C). The mid-point potentials (V50, act and V50, inact) of
activation and steady-state inactivation are exhibited as bar graphs in
Fig. 5D and E, and their values are listed inTable 1. Comparison of theV50
values for activation and steady-state inactivation suggests that
substitution of a Cav3.1 intracellular loop into Cav3.3 tends to negatively
shift the potentials (V50, act and V50, inact), except for the Cav3.1 C-
terminus which positively shifts them.
4. Discussion
The results of our systematic replacement of individual intracel-
lular and trans-membrane region(s) of Cav3.3 with the corresponding
region(s) of the Cav3.3 suggest that individual structural regions have
distinct effects on current kinetics. The main ﬁndings can be
summarized as follows. First, substitution of Cav3.1 III-IV loop in
Cav3.3 caused both the activation and inactivation kinetics of Cav3.3 toincrease more than any other intracellular and trans-membrane
structures. Second, substitution of the Cav3.1 I–II loop caused the
activation kinetics to speed up, but the inactivation kinetics to slow
down. Third, substitution of the Cav3.1 C-terminus accelerated the
inactivation kinetics without altering activation rates. Fourth, of the
four trans-membrane domains, substitution of Cav3.1 domains I or IV
prominently accelerated the activation and inactivation kinetics. Fifth,
substitution of Cav3.1 domains II or III accelerated inactivation rates
without altering activation rates. Sixth, substitution of the II–III loop
had little effect on activation or inactivation kinetics. These ﬁndings
displayed that individual intracellular loops and trans-membrane
domains differentially contributed to governing the current kinetics of
Cav3.3. However, the fact that none of the regions replaced was
sufﬁcient to totally transit the current kinetics of Cav3.3 to Cav3.1
suggests that multiple structural regions are involved in controlling
the activation and inactivation kinetics of the T-channels.
In an attempt to conﬁrm the critical role of III–IV loop, we
constructed a reverse mutant (named “GI34L”) of IG34L by replacing
the III–IV loop of Cav3.1 with the corresponding loop of Cav3.3.
Expression and characterization of GI34L showed that both the
activation and inactivation kinetics of GI34L were signiﬁcantly slower
Fig. 5. Comparison of biophysical properties. (A) Current–voltage relationships of wild-type Cav3.1, Cav3.3, and their chimeric channels. (B) Activation curves. The chord conductances
were obtained by dividing current amplitudes by driving forces (=apparent reversal potentials− test potentials), normalized to the peak conductance obtained, averaging, and then
plotting them against the test potentials. (C) Steady-state inactivation curves. Average percent inactivation is plotted as a function of prepulse potentials. Smooth curves represent
Boltzmannﬁts to the data. Symbols representingα1 subunits are as follows: Cav3.1 (⁎), Cav3.3 (×), IGNL (▪), IG12L (▴), IG23L (▾), IG34L (◆), IGCL (•), IGN+34L (□), IG12+34L (▵), IG23 +34L (▿),
IG34+CL (◊), IGAL (○), IGAL+DomI ( ), IGAL+DomII ( ), IGAL+DomIII ( ), and IGAL +DomIV ( ). (E and F), Bar graphs of the V50 values for activation and steady-state inactivation of the Cav3.1,
Cav3.3 and chimeric channels. Data represent mean±S.E.M. (n=6–23). Differences were evaluated by one-way ANOVA: ⁎, P<0.05; ⁎⁎⁎, P<0.001.
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(τact values of GI34L and Cav3.1 at −40 mV=7.1±0.6 vs 4.4±0.5,
P<0.01; τinact of GI34L and Cav3.1 at −40 mV=25.6±2.7 vs 16.7±1.5,
P<0.01, n=9–17, Student's t tests), but did not signiﬁcantly different
from Cav3.1 current kinetics at higher test potential than about
−30 mV (Supplementary information). These data suggested that the
slowdown of Cav3.1 current kinetics by adopting the Cav3.3 III–IV
loop was not as dramatic as the acceleration of Cav3.3 currentkinetics by adopting the Cav3.1 III–IV loop. One of the possible
interpretations for this discrepancy is that the III–IV loop is not
responsible for all of the faster gating properties, but multiple
structural regions including the III–IV loop contribute to setting the
current kinetics of Cav3.1.
It is notable that the critical contribution of the Cav3.1 III–IV loop
to accelerating the inactivation kinetics seems to mimic the fast
inactivation mechanism of various voltage-activated Na2+ channels in
2747H.-W. Kang et al. / Biochimica et Biophysica Acta 1778 (2008) 2740–2748which the IFM (Ile-Phe-Met) motif in the III–IV loop functions as an
inactivation ball, although no IFM-like motif is present in the T-
channel isoforms. Comparison of the III–IV loop sequences of Cav3.1,
its splice variants, and Cav3.3 shows that they have strong sequence
similarity, but that the Cav3.1 loop contains the additional amino acid
sequence “Ser-Lys-Glu-Lys-Gln-Met-Ala (SKEKQMA)” in its central
region. There are previous reports that a Cav3.1 splice variant
(Cav3.1a) containing “SKEKQMA” in the center of the III–IV loop had
faster activation and inactivation kinetics than another Cav3.1 splice
variant (Cav3.1b) lacking this sequence, implying that it makes an
important contribution to accelerating activation and inactivation
kinetics [19,20]. Based on this inference, we propose that “SKEKQMA”
acts as an inactivation ball for fast inactivation of the Cav3.1 channel.
We have tested this hypothesis by seeing whether the current kinetics
of the Cav3.3 channel could be altered by coexpression of a Cav3.1 III–
IV loop cRNA or by injecting a commercially synthesized “Ser-Lys-Glu-
Lys-Gln-Met-Ala-Glu” peptide. However, coexpression of the III–IV
loop or injection of the peptide did not alter the current kinetics of
Cav3.3 (data not shown). Thus, although we did not obtain any
evidence to support this postulate, it would be desirable to see
whether injection of antibodies speciﬁcally developed against the
whole III–IV loop or the central peptide modulate the current kinetics
of the Cav3.1 channel.
The ﬁnding that substitution of the Cav3.1 I–II loop into Cav3.3
speeded up the activation rates, but reduced the inactivation rates of
Cav3.3 implies that the Cav3.1 I–II loop contains regions responsible for
different effects on activation and inactivation rates. Recently, Vitko
and her colleagues reported that the N- and C-terminal regions of loop
I–II participate in regulating the current kinetics as well as voltage
dependence of channel activation and inactivation, whereas the
middle region of the loop is involved inmodulating surface expression
without affecting biophysical behavior [21]. The N-terminal regions of
loops I–II of Cav3.1 and Cav3.3 are very similar, whereas their middle
and C-terminal regions are not. We therefore speculate that the C-
terminal region of the substituted Cav3.1 I–II loop is likely to be a
critical determinant of current kinetics.
Replacement of the Cav3.3 carboxyl terminus with its counterpart
in Cav3.1 accelerated the inactivation kinetics without changing the
activation kinetics. This result is consistent with a report describing a
crucial contribution of the C-terminus to the inactivation kinetics [16],
but different from reports claiming a less important role for the C-
terminus [17,18]. One possible explanation of the different ﬁndings is
that the switched C-terminus has a different effect depending on the
batches of oocytes and the expression systems used.
The outcome of serial substitution of the trans-membrane
domains of Cav3.1 into IGAL suggested that the individual trans-
membranes domains make different contributions to the regulation
of current kinetics: domains I, II, III, and IV contribute to inactivation
kinetics with the domain I more critical than the other domains,
while domains I and IV affect the activation kinetics and make
roughly equal contributions. Combined with the results from the
loop chimeric channels, these ﬁndings suggest that the critical
structural determinants governing the inactivation kinetics are
localized in domain I as well as in the III–IV loop, rather than
being evenly spread over all the whole Cav3.3 structure. We
previously reported that both half–half chimeric channels (G-G-I-I
and I-I-G-G) between fast Cav3.1 (G-G-G-G) slow Cav3.3 (I-I-I-I)
displayed similar inactivation kinetics with time constants halfway
between those of Cav3.1 and Cav3.3 [17]. Our earlier explanation that
each half contributes similarly to inactivation can now be reﬁned by
saying that the structural determinant(s) for inactivation are
localized in domain I of the ﬁrst half and in the III–IV loop of the
second half.
Our ﬁnding that the III–IV loop makes the major contribution to
current kinetics is consistent with Hamid's recent ﬁnding that the
domain IV region is the most important structural region, because thedomain IV region that Hamid and his colleagues examined included
not only the domain IV region, but also the preceding III–IV loop [18].
In addition, our studies support the main conclusion of the previous
reports that multiple structural regions participate in controlling the
current kinetics of T-type channels as well as the half-activation and
half-inactivation potentials [17,18].
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